2015
DOI: 10.4049/jimmunol.1402670
|View full text |Cite
|
Sign up to set email alerts
|

Negative Regulation of Memory Phenotype CD8 T Cell Conversion by Adhesion and Degranulation–Promoting Adapter Protein

Abstract: The maintenance of T cell repertoire diversity involves the entry of newly developed T cells, as well as the maintenance of memory T cells generated from previous infections. This balance depends on competition for a limited amount of homeostatic cytokines and interaction with self-peptide MHC-I. In the absence of prior infection, memory-like or memory phenotype (MP) CD8 T cells can arise from homeostatic cytokine exposure during neonatal lymphopenia. Aside from downstream cytokine signaling, little is known a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
24
1

Year Published

2016
2016
2018
2018

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 20 publications
(25 citation statements)
references
References 31 publications
0
24
1
Order By: Relevance
“…Although we and others have demonstrated defects in T-APC contacts, entry of T cells into the cell cycle, proliferation, differentiation and survival in the absence of ADAP (1317, 19, 21), several recent reports have documented a negative regulatory function for ADAP in T cells (22, 23). We have recently shown that ADAP-deficient T cells have an enhanced response to weak agonist peptide ligands in naïve CD8 T cells (22).…”
Section: Introductionmentioning
confidence: 61%
See 4 more Smart Citations
“…Although we and others have demonstrated defects in T-APC contacts, entry of T cells into the cell cycle, proliferation, differentiation and survival in the absence of ADAP (1317, 19, 21), several recent reports have documented a negative regulatory function for ADAP in T cells (22, 23). We have recently shown that ADAP-deficient T cells have an enhanced response to weak agonist peptide ligands in naïve CD8 T cells (22).…”
Section: Introductionmentioning
confidence: 61%
“…Ex vivo conjugate assays were performed by modifying our previously described conjugate assay (14, 15, 18, 21, 22), using splenic dendritic cells enriched from mice treated for 14 days with a B16 tumor expressing FLT3 ligand (33). Briefly, single cell suspensions obtained from spleens of FLT3 conditioned mice, which contained 25–35% CD11c + MHCII + dendritic cells, were labeled with Cell Tracker Orange (CTO, Thermo Fisher) as previously described (14, 15, 18, 21, 22) and then pulsed with the indicated doses of SIINFEKL peptide for 30 mins at 37C in warm TCPM, washed, and resuspended at 5 x 10 6 cells/ml in pre-warmed TCPM.…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations